None · None

FORTREA HLDGS INC FTRE

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Company profile

Business mix

  • It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics.
  • The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services.
  • Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Current key questions

  • Can the company's products, services, or pipeline expand adoption within biotechnology?
  • How do reimbursement, regulation, clinical data, patents, and commercial execution affect growth?
  • Can margins and cash flow improve while funding research, manufacturing, or go-to-market investment?
Holders 2 Current sample portfolio
Public mentions 0 Videos / interviews / letters

Current firm holders

Firm Weight Value Filing period
Corvex Management Keith Meister 1.7% $43.7M 2026-03-31
Sessa Capital 0.8% $43.3M 2026-03-31

Recent trading changes over the last 2 quarters

Net buyers 2 Last 2 13F filing periods
Net reducers 1 Last 2 13F filing periods
Unchanged holders 0 Share count unchanged
Increase amount $6.9M Estimated from net added shares
Reduction amount $39.8M Estimated from net reduced shares
Net share change / base shares -32.9% -4,532,338 / 13,770,081
Corvex Management Keith Meister 2 filing periods
13F 2025-12-31 Filed 2026-02-17
Unchanged Shares 0.0% 13F value change $0
13F 2026-03-31 Filed 2026-05-15
Minor increase Shares 3.0% 13F value change -$34.0M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 4,508,531 Last 2 periods +135,662 (+3.0%) Total shares 4,644,193 Value $43.7M
Sessa Capital 2 filing periods
13F 2025-12-31 Filed 2026-02-17
Unchanged Shares 0.0% 13F value change $0
13F 2026-03-31 Filed 2026-05-15
Major increase Shares 15.0% 13F value change -$25.6M
Settlement As of 13F 2026-03-31 · Filed 2026-05-15
Base shares 3,993,550 Last 2 periods +600,000 (+15.0%) Total shares 4,593,550 Value $43.3M
Starboard Value Jeff Smith 2 filing periods
13F 2025-06-30 Filed 2025-08-14
Major reduction Shares -52.6% 13F value change -$27.4M
13F 2025-09-30 Filed 2025-11-14
Sold out Shares -100.0% 13F value change -$12.3M
Settlement As of 13F 2025-09-30 · Filed 2025-11-14
Base shares 5,268,000 Last 2 periods -5,268,000 (-100.0%) Total shares 0 Value $0

Recent mentions

No public mentions.